Trinity Biotech (Trinity Biotech) Total Inventories : $19.93 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Total Inventories?

Trinity Biotech's total inventories for the quarter that ended in Dec. 2023 was $19.93 Mil. Trinity Biotech's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $20.41 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Trinity Biotech's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-8.05.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Trinity Biotech's Days Inventory for the three months ended in Dec. 2023 was 210.14.

Inventory Turnover measures how fast the company turns over its inventory within a year. Trinity Biotech's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.43.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Trinity Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.52.

Trinity Biotech Total Inventories Historical Data

The historical data trend for Trinity Biotech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Total Inventories Chart

Trinity Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

32.02

30.22

29.12

22.50

19.93

Trinity Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															22.50	21.53	22.58	20.88	19.93

Trinity Biotech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Trinity Biotech (NAS:TRIB) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Trinity Biotech's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(3.691	+	0.75 * 10.698	+	0.5 * 19.933	-	83.384
-	0	-	0)	/	7.66551
=	-8.05

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Trinity Biotech's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	20.4065	/	8.861	*	365 / 4
	=	210.14

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Trinity Biotech's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	8.861	/	20.4065
	=	0.43

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Trinity Biotech's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	20.4065	/	13.428
	=	1.52

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Trinity Biotech Total Inventories Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Trinity Biotech (Trinity Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Total Inventories

Comparable Companies

STRR CNTG CHEK PMD MYNZ SLDX PRPO XWEL PCHM DMTK TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

TRBA:Germany

Address

IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8

Website

https://www.trinitybiotech.com

Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.